MAGNESIUM L-GLUTAMATE TETRAHYDRATE

Possibly Marketed Outside US

Details

Stereochemistry	ABSOLUTE
Molecular Formula	2C5H7NO4.Mg.2H.4H2O
Molecular Weight	388.6088
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of MAGNESIUM L-GLUTAMATE TETRAHYDRATE

Structure Search

SMILES

[H+].[H+].O.O.O.O.[Mg++].N[C@@H](CCC([O-])=O)C([O-])=O.N[C@@H](CCC([O-])=O)C([O-])=O

InChI

InChIKey=ZWCGDRSVJYJGFY-GYDBBPQESA-L

InChI=1S/2C5H9NO4.Mg.4H2O/c2*6-3(5(9)10)1-2-4(7)8;;;;;/h2*3H,1-2,6H2,(H,7,8)(H,9,10);;4*1H2/q;;+2;;;;/p-2/t2*3-;;;;;/m00...../s1

HIDE SMILES / InChI

Molecular Formula	H2O
Molecular Weight	18.0153
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	2C5H7NO4.Mg.2H.4H2O
Molecular Weight	388.6088
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	Mg
Molecular Weight	24.305
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C5H9NO4
Molecular Weight	147.1293
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/680616 | http://www.druginfosys.com/drug.aspx?drugcode=1321&type=1https://noshly.com/additive/e625/flavour-enhancer/625/ | http://www.thegoodscentscompany.com/data/rw1609401.html | http://www.foodadditiveslist.com/page/55/ | http://www.fao.org/ag/agn/jecfa-additives/specs/Monograph1/Additive-259.pdf

Food additive, flavour enhancer, salt substitute - iImproves the taste and/or aroma of foods.

CNS Activity

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Psychotic disorder 26 Sources: https://www.ncbi.nlm.nih.gov/pubmed/680616 https://www.ncbi.nlm.nih.gov/pubmed/4849930	Primary		Approved 8429	PSYCHOVERLAN Approved Use Nervous system disorders
Unknown 2578

PubMed

Title	Date	PubMed
[Long-term treatment with psychoverlan in children and adolescents with behavior disorders].	1978 Aug 24	680616

Patents

Sample Use Guides

In Vivo Use Guide

In a long-term study 19 young females were treated with Psychoverlan capsules or syrup for an average of 11.4 months. Magnesium positive role is not only for the psychiatric illness but study highlight about the auditory brain stem problem in a study found use of super aliments of magnesium auditory brain stem problem reduced. Magnesium ideal dose is 125-300 mg /day.

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Sat Dec 16 10:09:50 UTC 2023` Edited by `admin` on `Sat Dec 16 10:09:50 UTC 2023`
Record UNII	S8TL3KXK0I
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MAGNESIUM L-GLUTAMATE TETRAHYDRATE

Systematic Name

English

L-GLUTAMIC ACID, MAGNESIUM SALT (2:1), TETRAHYDRATE

Common Name

English

MAGNESATE(2-), BIS(L-GLUTAMATO(2-)-N,O1)-, DIHYDROGEN, TETRAHYDRATE, (T-4)-

Systematic Name

English

MAGNESIUM DI-L-GLUTAMATE

Systematic Name

English

Code System Code Type Description

CODEX ALIMENTARIUS (GSFA)

INS-626